Study to Evaluate IMG-004 in Healthy Participants
Public ClinicalTrials.gov record NCT05349097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Administered IMG-004 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Dose(s) and an Open-Label Study of Single Oral Dose of IMG-004 to Evaluate the Food Effect in Healthy Participants
Study identification
- NCT ID
- NCT05349097
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Inmagene LLC
- Industry
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- SAD IMG-004 30mg Drug
- SAD IMG-004 100mg Drug
- SAD IMG-004 200mg Drug
- SAD IMG-004 400mg Drug
- SAD IMG-004 600mg Drug
- SAD Placebo 30mg Drug
- SAD Placebo 100mg Drug
- SAD Placebo 200mg Drug
- SAD Placebo 400mg Drug
- SAD Placebo 600mg Drug
- MAD IMG-004 50mg Drug
- MAD Placebo 50mg Drug
- MAD IMG-004 150mg Drug
- MAD Placebo 150mg Drug
- MAD IMG-004 300mg Drug
- MAD Placebo 300mg Drug
- FE IMG-004 150mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2022
- Primary completion
- May 1, 2024
- Completion
- May 1, 2024
- Last update posted
- May 16, 2024
2022 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Labcorp Cru | Daytona Beach | Florida | 32117-5116 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05349097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05349097 live on ClinicalTrials.gov.